• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

SANDOZ GROUP N (SDZ)

Sell: 73.00 CHF|Buy: 74.50 CHF|Change: 0.24 (0.33%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 30 assets in its pipeline.

Address




Website

https://www.sandoz.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Sandoz Group AG Second Quarter Earnings Results for 20272027-08-05T00:00:00
Sandoz Group AG Annual General Meeting for 20272027-04-09T00:00:00
Sandoz Group AG Fourth Quarter Earnings Conference Call for 20262027-02-25T09:30:00
Sandoz Group AG Fourth Quarter Earnings Results for 20262027-02-25T00:00:00
Sandoz Group AG Annual Report for 20262027-02-25T00:00:00
Sandoz Group AG Third Quarter Earnings Conference Call for 20262026-10-30T09:00:00
Sandoz Group AG Third Quarter Earnings Results for 20262026-10-30T00:00:00
Sandoz Group AG Second Quarter Earnings Results for 20262026-08-05T00:00:00

Previous key dates

NameKey Date
Sandoz Group AG Second Quarter Earnings Results for 20262026-08-05T00:00:00
Sandoz Group AG Annual General Meeting for 20262026-04-09T00:00:00
Jefferies Pan-European Mid-Cap Conference2026-03-25T00:00:00
BNP Paribas Exane Healthcare Conference2026-03-24T00:00:00
Bank of America Pharma Bus Tour2026-03-12T00:00:00
Barclays Global Healthcare Conference2026-03-10T00:00:00
Full-Year 2025 European Roadshow2026-03-03T00:00:00
Full-Year 2025 North American Roadshow2026-03-03T00:00:00
Sandoz Group AG Fourth Quarter Earnings Conference Call for 20252026-02-25T09:30:00
Sandoz Group AG Fourth Quarter Earnings Result for 20252026-02-25T00:00:00
Sandoz Group AG Annual Report for 20252026-02-25T00:00:00
Sandoz Group AG Third Quarter Earnings Conference Call for 20252025-10-30T09:00:00
Sandoz Group AG Third Quarter Earnings Result for 20252025-10-30T00:00:00
Sandoz Group AG Second Quarter Earnings Results for 20252025-08-07T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.